http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2253449-C1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L2-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
| filingDate | 2003-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c53326223ae32d48d8d8f8a448e06b71 |
| publicationDate | 2005-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2253449-C1 |
| titleOfInvention | Method for eradication of infection heliobacter pylory in stomach |
| abstract | FIELD: gastroenterology. n SUBSTANCE: eradication of infection Heliobacter pylory in stomach comprises oral administration of corresponding drugs in powdered form mixed with orange juice. In particular, mixture of colloidal bismuth subcitrate (De-nol), Nifuratel (Macmirror), and Amoxycyllin (Flemoxin solutab) are used. Administration is performed on an empty stomach at least 30-40 min before the food intake. Patient then lies at least 30 min on the both sides alternatively. n EFFECT: suppressed water-repellent property of near-wall layer of stomach mucus and slowed down evacuation of liquid from stomach thereby ensuring fast diffusion of therapeutical substances into infect persisting zone and, therefore, direct bactericidal effect on Heliobacter pylory. n 4 cl |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2452497-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2467758-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2699567-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2475754-C2 |
| priorityDate | 2003-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 47.